Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
FDA Recall #D-0608-2025 — Class II — July 9, 2025
Product Description
Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Reason for Recall
Subpotent Drug
Recalling Firm
Boothwyn Pharmacy LLC — Kennett Square, PA
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
186 vials
Distribution
U.S. Nationwide
Code Information
03202025@9 BUD 07/18/2025
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated